National guidelines of diagnosis and treatment of the non-Hodgkin lymphoma

被引：0

作者：

Candelaria, Myrna ^{[1
]}

Cervera-Ceballos, Eduardo ^{[2
]}

Meneses-Garcia, Abelardo ^{[3
]}

Aviles-Salas, Alejandro ^{[4
]}

Lome-Maldonado, Carmen ^{[5
]}

Zarate-Osorno, Alejandra ^{[6
]}

Ortiz-Hidalgo, Carlos

Rodriguez-Mogue, Leticia ^{[7
]}

Enedina Quinonez-Urrego, Enoe ^{[8
]}

Ramos-Salazar, Patricia ^{[9
]}

Belinda Romero-Guadarrama, Monica ^{[10
]}

Lara-Torres, Cesar ^{[11
]}

Ramirez-Aceves, Rock ^{[12
]}

Lopez-Navarro, Omar ^{[13
]}

Rivas-Vera, Silvia ^{[3
]}

Eudaldo Diaz-Meneses, Ivan ^{[14
]}

Estrada-Lobato, Enrique ^{[15
]}

Cervera-Ceballos, Jose ^{[16
]}

Enrique Rojas-Marin, Carlos ^{[3
]}

Mario Hernandez-Rodriguez, Jose

Perez-Lopez, Berenice ^{[17
]}

Gomez-Almaguer, David ^{[18
]}

Altamirano-Ley, Javier ^{[19
]}

Baz, Patricia ^{[3
]}

Manuel Valero-Saldana, Luis ^{[20
]}

Rene Navarrete-Herrera, Jose ^{[21
]}

Gerardo Torres-Salgado, Francisco ^{[22
]}

Solano-Murillo, Pedro ^{[23
]}

de Jesus Nannbo-Lucio, Maria ^{[24
]}

Rivas-Llamas, Ramon ^{[25
,26
]}

Luis Aquino-Salgado, Jorge ^{[27
]}

Veronica Avila-Arreguin, Elsa ^{[28
]}

Cortes-Esteban, Patricia ^{[29
]}

Lilia Chongo-Alfaro, Martha ^{[3
]}

de Jesils Perez-Ramirez, Oscar ^{[30
]}

Vanesa Toledano-Cuevas, Diana ^{[3
]}

Lobato-Mendizaba, Eduardo ^{[31
]}

Alberto Martinez-Ramirez, Mario ^{[32
]}

Morales-Maravilla, Adrian ^{[33
]}

Elena Sosa-Camas, Rosa ^{[34
]}

Agreda-Vasquez, Gladys P. ^{[35
]}

Camacho-Hernandez, Alejandro ^{[36
]}

Aguayo-Gonzalez, Alvaro ^{[35
]}

Ramiro Espinoza-Zamora, Jose ^{[3
]}

Sanchez-Guerrero, Sergio A. ^{[37
]}

Lozano-Zavaleta, Valentin ^{[3
]}

Edgar Selva-Pallares, Julio ^{[38
]}

Manuel Hernandez-Rodriguez, Juan ^{[39
]}

Cardiel-Silva, Mariela ^{[40
]}

Hector Castillo-Rivera, Manuel ^{[41
]}

机构：

[1] Inst Nacl Cancerol INCan, Unidad Func Hematol, Mexico City, DF, Mexico

[2] Docencia INCan, Mexico City, DF, Mexico

[3] INCan, Mexico City, DF, Mexico

[4] INCan, Dept Patol Quirdrg, Mexico City, DF, Mexico

[5] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

[6] Hosp Espanol, Mexico City, DF, Mexico

[7] Lab Patol Sureste, Mexico City, DF, Mexico

[8] Patol Ctr Med Nacl La Raza, Mexico City, DF, Mexico

[9] Ctr Med Nacl La Raza, IMSS, Mexico City, DF, Mexico

[10] Patol Hosp Gen Mexico, SS, Mexico City, DF, Mexico

[11] Patol Ctr Oncol Estatal ISSEMYM Ctr, Toluca, Mexico

[12] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl Siglo 21, IMSS, Serv Anatomfa Patol, Mexico City, DF, Mexico

[13] Ctr Invest Biomed Occidente, CMNO, INCan, Guadalajara, Jalisco, Mexico

[14] Med Nucl INCan, Inst Nacl Neurol & Neurocirugia Mexico, Mexico City, DF, Mexico

[15] INCan, Dept Nucl Med, Mexico City, DF, Mexico

[16] Hosp Gelenia, Dept Imagenol, Cancun, Mexico

[17] IMSS, DIM, Mexico City, DF, Mexico

[18] Univ Autonoma Nuevo Leon, Univ Hosp, San Nicolas De Los Garza, Mexico

[19] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico

[20] INCan, Programa Trasplante Progenitores Hematopoyet, Mexico City, DF, Mexico

[21] Ctr Especialidades Merlins, Unidad Hematol Oncol, Mexico City, DF, Mexico

[22] Hosp Aranda Parra, Leon, Mexico

[23] CMO IMSS, Dept Clin Oncol Med, Mexico City, DF, Mexico

[24] Hosp Oncol, Ctr Medo Nacl Siglo 21, IMSS, Mexico City, DF, Mexico

[25] Hosp Gen Culiacan, Banco Sangre, Dept Hematol, Culiacan, Sinaloa, Mexico

[26] Hosp Gen Culiacan, Unidad Aferesis, SSA, Culiacan, Sinaloa, Mexico

[27] Hosp Reg Alta Especialidad Oaxaca, Oaxaca, Mexico

[28] Hosp Especialidades Ctr Med La Raza, Ctr Med Nacl La Raza, IMSS, Guadalajara, Jalisco, Mexico

[29] Ctr Med Nacl, ISSSTE, Mexico City, DF, Mexico

[30] Univ Autonoma San Luis Potosi, Fac Med, Hosp Cent Ignacio Morones, San Luis Potosi, Mexico

[31] Hosp Angeles Puebla, Serv Hematol, Puebla, Mexico

[32] IMSS, Veracruz Puerto, Veracruz, Mexico

[33] SSEP, Unidad Oncol, Puebla, Mexico

[34] Hosp Gen Estado, Serv Hematol, Hermosillo, Sonora, Mexico

[35] INCMNSZ, Dept Hematol & Oncol, Mexico City, DF, Mexico

[36] Hosp Gen SSA, Serv Hematol, Sonora, Mexico

[37] INCan, Dept Banco Sangre, Caracas, Mexico

[38] UNHE T Joaquin Clausell Tijuana, Tijuana, BC, Canada

[39] Hosp Gen Reg SSG Leon, Serv Hematol, Sanatorio Moderno Banco Sangre, Sonora, Mexico

[40] ISSSTE Hosp Gen 26 RAC, Centenario Hosp Miguel Hidalgo SSA, Aguascalientes, Mexico

[41] HGR1, Sonora, Mexico

[42] Escuela Med & Ciencias Salud, Ctr Med Zambrano Hell Tec Salud, Monterrey, NL, Mexico

[43] Univ Valle Mexico, Hosp Angeles Queretaro, Mexico City, DF, Mexico

[44] Hosp Reg Alta Especialidad, Veracruz, Mexico

[45] Angeles Villahermosa, Villahermosa, Mexico

[46] Hosp Cent PEMEX, Mexico City, DF, Mexico

[47] Estatal ISSEMYM Ctr, Ctr Oncol, Metepec, Mexico

[48] PEMEX, Mexico City, DF, Mexico

[49] Hosp Reg Ohoran, Serv Salud Yucatan, Programa Seguro Popular, Clin Linfomas, Merida, Mexico

[50] Ctr Med Nacl 20 Noviembre, Med Oncol Serv, ISSSTE, Mexico City, DF, Mexico

来源：

REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 2013年 / 65卷

关键词：

Non-Hodgkin lymphoma; Treatment; Guidelines; Lymphoma; T-CELL LYMPHOMA; PEGYLATED LIPOSOMAL DOXORUBICIN; CLINICAL-PRACTICE GUIDELINES; HIGH-DOSE CHEMOTHERAPY; TERM-FOLLOW-UP; FOLLICULAR LYMPHOMA; NASAL-TYPE; MYCOSIS-FUNGOIDES; LOW-GRADE; PHASE-II;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Non-Hodgkin lymphoma comprises a heterogeneous group of haematological malignancies, classified according to their clinic, anatomic-pathological features and, lately, to their molecular biomarkers. Despite the therapeutic advances, nearly half of the patients will die because of this disease. The new diagnostic tools have been the cornerstone to design recent therapy targets, which must be included in the current treatment guidelines of this sort of neoplasms by means of clinical trials and evidence-based medicine. In the face of poor diagnoses devices in most of the Mexican hospitals, we recommend the present diagnose stratification, and treatment guidelines for non-Hodgkin lymphoma, based on evidence. They include the latest and most innovative therapeutic approaches, as well as specific recommendations for hospitals with limited framework and therapy resources.

引用

页码：S5 / S27

页数：23

共 50 条

[21] Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma
Kathleen M. McCarten
Helen R. Nadel
Barry L. Shulkin
Steve Y. Cho
Pediatric Radiology, 2019, 49 : 1545 - 1564
[22] Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma
McCarten, Kathleen M.
Nadel, Helen R.
Shulkin, Barry L.
Cho, Steve Y.
PEDIATRIC RADIOLOGY, 2019, 49 (11) : 1545 - 1564
[23] Romidepsin for the treatment of non-Hodgkin's lymphoma
Yazbeck, Victor Y.
Grant, Steven
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (07) : 965 - 979
[24] New treatment option for non-Hodgkin lymphoma
Boughton, B
LANCET ONCOLOGY, 2002, 3 (02): : 69 - 69
[25] A revolution in the treatment of non-Hodgkin's lymphoma
DeNardo, GL
O'Donnell, RT
Oldham, RK
DeNardo, SJ
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1998, 13 (04) : 213 - 223
[26] Pixantrone for the treatment of aggressive non-Hodgkin lymphoma
Mukherji, Deborah
Pettengell, Ruth
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (11) : 1915 - 1923
[27] Advances in the treatment of non-Hodgkin's lymphoma
Cerny, T
Gillessen, S
ANNALS OF ONCOLOGY, 2002, 13 : 211 - 216
[28] Bortezomib for the treatment of non-Hodgkin's lymphoma
Bose, Prithviraj
Batalo, Michael S.
Holkova, Beata
Grant, Steven
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (16) : 2443 - 2459
[29] CYTOSTATICS THERAPY IN THE TREATMENT OF NON-HODGKIN LYMPHOMA
KRATZER, H
DENZ, H
BLIEM, J
HUBER, H
MICHLMAYR, G
ACTA MEDICA AUSTRIACA, 1981, 8 : 193 - 193
[30] Treatment of aggressive non-Hodgkin's lymphoma
Coiffier, B
SEMINARS IN ONCOLOGY, 1999, 26 (05) : 12 - 20

← 1 2 3 4 5 →